Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine plus CAG regimen in elderly acute myeloid leukemia
ChiCTR-ONC-11001700Phase 2Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Sep 2011
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of decitabine, aclarubicin, cytarabine and granulocyte colony-stimulating factor in acute myeloid leukemia (AML), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: Complete remission rate and Partial remission rate. Started Sep 2011; status: recruiting.
02
Drugs
decitabineaclarubicincytarabinegranulocyte colony-stimulating factor
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on ChiCTR-ONC-11001700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-11001700.